ArticleTranslational oncology2025

BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair.

Shuaishuai Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.